Skip to main content

Advertisement

SpringerLink
Log in

The role of TNF in diverse pathologic processes

  • Published:
Biotherapy

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

IL-1:

Interleukin 1

PGE2 :

Prostaglandin

TGE-beta:

Growth Transforming factor-beta

References

  1. Hohmann HP, Remy G, Brockhaus M, van-Loon AP. Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). J Biol Chem 1989; 264: 14927–34.

    PubMed  Google Scholar 

  2. Smith RA, Baglioni C. Multimeric structure of the tumor necrosis factor receptor of HeLa cells. J Biol Chem 1989; 264: 14646–52.

    PubMed  Google Scholar 

  3. Peetre C, Gullberg U, Nilsson E, Olsson I. Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cellsin vitro. J Clin Invest 1986; 78: 1694–703.

    PubMed  Google Scholar 

  4. Jelinek DF, Lipsky PE. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor alpha and interleukin-1. J Immunol 1987; 139: 2970–81.

    PubMed  Google Scholar 

  5. Bachwich PR, Chensue SW, Larrick JW, Kunkel SL. Tumour necrosis factor stimulates interleukin-1 and prostaglandin E production in resting macrophages. Biochem Biophys Res Comm 1986; 136: 94–101.

    PubMed  Google Scholar 

  6. Phillip R, Epstein L. Tumor necrosis factor as immunomodular and mediator of monocyte cytotoxicity induced by itself, gamma interferon, and interleukin-1. Nature 1986; 323: 86–91.

    PubMed  Google Scholar 

  7. Larrick JW, Graham D, Toy K, Lin LS, Senky G, Fendly BM. Recombinant tumor necrosis factor causes activation of human granulocytes. Blood 1987; 69: 640–52.

    PubMed  Google Scholar 

  8. Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factor. J Immunol 1985; 135: 2069–78.

    PubMed  Google Scholar 

  9. Strieter, RM, Phan SH, Showell HJ, Remick DG, Lynch JP, Genord M, Raiford C, Eskandari M, Marks R, Kunkel SL. Monokine induced neutrophil chemotactic factor gene expression in human fibroblasts. J Biol Chem 1989; 264: 10621–6.

    PubMed  Google Scholar 

  10. Van Damme J, Dieckmann B, Simpson J, Rubira MR, Cayhas S, Vink A, Billiau A, van Snick J. Identification of the human 26-Kd protein, interferon beta-2 as a B cell hybridroma/plasmacytoma growth factor induced by interleukin-1 and tumor necrosis factor. J Exp Med 1987; 165: 914–23.

    PubMed  Google Scholar 

  11. Stricter RM, Kunkel SL, Showell HJ, Remick DG, Phan SH, Ward PA, Marks R. Endothelial cells gene expression of a neutrophil chemotactic factor by TNF, IL-1, and LPS. Science (Wash DC) 1989; 243: 1467–9.

    Google Scholar 

  12. Pohlman TH, Stanness KA, Beatty PG, Ochs HD, Harlan JM. An endothelial cell surface factor(s) inducedin vitro by LPS, IL-1, and TNF-alpha increases neutrophil adherences by a CDW 18-dependent mechanism. J Immunol 1986; 136: 4548–54.

    PubMed  Google Scholar 

  13. Elner VM, Stricter RM, Elner SG, Kunkel SL. Human retinal pigment epithelial cells produce neutrophil chemotactic factor in response to IL-l, TNF, and LPS. Am J Pathol 1990 (in press).

  14. Carswell EA, Old LJ, Kassel RL, Green S, Fiknore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975; 72: 3666–70.

    PubMed  Google Scholar 

  15. Bender B, Cerami A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 1986; 320: 584–9.

    PubMed  Google Scholar 

  16. Beutler B, Mahoney J, LeTrang N, Pekala P, Cerami A. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW-264.7 cells. J Exp Med 1985; 161: 984–91.

    PubMed  Google Scholar 

  17. Beulter B, Milsark IW, Cerami A. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science 1985; 229: 869–73.

    PubMed  Google Scholar 

  18. Tracy KJ, Beutler B, Lowrey SL, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ, Albert JD, Shires GT, Cerami A. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470–5.

    PubMed  Google Scholar 

  19. Gilbert RP. Mechanisms of the hemodynamic effects of endotoxin. Physiol Rev 1960; 40: 245–68.

    PubMed  Google Scholar 

  20. Morgan HR. Pathologic changes produced in rabbits by a toxic somatic antigen derived from Eberthella typhosa. Am J Pathol 1942; 135–43.

  21. Mathison JC, Wolfson E, Ulevitch RJ. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest 1988; 81: 1925–38.

    PubMed  Google Scholar 

  22. Kettelhut IC, Fiers W, Goldberg AL. The toxic effects of tumor necrosis factorin vivo and their prevention by cyclooxygenase inhibitors. Proc Natl Acad Sci USA 1987; 84: 4273–81.

    PubMed  Google Scholar 

  23. Tracey KJ, Lowrey SL, Fahey TS, Albert JD, Fong Y, Hesse D, Beutler B, Monague KR, Calvano S, Wei H, Cerami A. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet 1987; 164: 415–23.

    PubMed  Google Scholar 

  24. Waage A, Espevik T, Lamvik J. Detection of tumour necrosis factor-like cytotoxicity in serum from patients with septicaemia but not from untreated cancer patients. Scand J Immunol 1986; 24: 739–46.

    PubMed  Google Scholar 

  25. Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; 1: 3557.

    Google Scholar 

  26. Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg 1976; 184: 333–41.

    PubMed  Google Scholar 

  27. Sprung CL, Caralis PV, Marcial EH, Pierce M. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med 1984; 311: 1137–40.

    PubMed  Google Scholar 

  28. Remick DG, Strieter RM, Lynch JP, Nguyen D, Eskandari M, Kunkel SL.In vivo dynamics of murine tumor necrosis factor-alpha gene expression. Kinetics of dexamethasone-induced suppression. Lab Invest 1989; 60: 766–71.

    PubMed  Google Scholar 

  29. Spengler RN, Spengler M, Lincoln P, Remick DR, Stricter RM, Kunkel S. Dynamics of dibutyryl cyclic AMP and Prostaglandin E-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha gene expression. Infect Immun 1989; 57: 2837–41.

    PubMed  Google Scholar 

  30. Scuderi P, Sterling K, Lam K, Finley P, Ryan K, Ray C, Petersen E, Slymen D, Salmon S. Raised serum levels of tumor necrosis factor in parasitic infections. Lancet 1986; 2: 1364–5.

    PubMed  Google Scholar 

  31. Saxne T, Palladino MA, Heinegard D, Tatal N, Wollheim FA. Detecting of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988; 31: 1041–5.

    PubMed  Google Scholar 

  32. Maury CJ, Teppo AM. Raised serum levels of cachectin/tumor necrosis factor in renal allograft rejection. J Exp Med 1987; 166: 1132–7.

    PubMed  Google Scholar 

  33. Lahdevirta J, Maury CP, Tepp AM, Rap H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85: 289–91.

    PubMed  Google Scholar 

  34. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA. The role of tumor necrosis factor in the pathophysiologic alterations following hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990 (in press).

  35. Remick DG, Kunkel RG, Larrick JW, Kunkel SL. Acutein vivo effects of human recombinant tumor necrosis factor. Lab Invest 1987; 56: 583–90.

    PubMed  Google Scholar 

  36. Magilavy DB, Rothstein JL. Spontaneous production of tumor necrosis factor alpha by Kupffer cells of MRL/lps mice. J Exp Med 1988; 168: 789–94.

    PubMed  Google Scholar 

  37. Lowry RP, Blais D. Tumor necrosis factor-alpha in rejecting rat cardiac allografts. Transplant Proc 1988; 20: 245–7.

    Google Scholar 

  38. Spriggs DR, Sherman ML, Michie H, Arthur KA, Imamura K, Wilmore D, Frei E III, Kufe DW. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study. JNCI 1988; 80: 1039–44.

    PubMed  Google Scholar 

  39. Abramowicz D, Schandene L, Goldman M, Crusiaux A, Vereerstraeten P, De Pauw L, Wybran J, Kinnaert P, DuPont E, Toussaint C. Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injectino of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation 1989; 47: 606–8.

    PubMed  Google Scholar 

  40. Chatenoud L, Ferran C, Reuter A, Legendre C, Gevaert Y, Kreis H, Franchimont P, Bach JF. Systematic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma. N Engl J Med 1989; 320: 1420–1.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Michigan, Medical School, 1301 Catherine Road, 48109-0602, Ann Arbor, Michigan, USA

    Steven L. Kunkel, Steven W. Chensue & Daniel G. Remick

  2. Department of Internal Medicine, University of Michigan, Medical School, 1301 Catherine Road, 48109-0602, Ann Arbor, Michigan, USA

    Robert M. Strieter

  3. Department of Surgery, University of Michigan, Medical School, 1301 Catherine Road, 48109-0602, Ann Arbor, Michigan, USA

    Darrel A. Campbell

Authors
  1. Steven L. Kunkel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert M. Strieter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steven W. Chensue
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Darrel A. Campbell
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daniel G. Remick
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kunkel, S.L., Strieter, R.M., Chensue, S.W. et al. The role of TNF in diverse pathologic processes. Biotherapy 3, 135–141 (1991). https://doi.org/10.1007/BF02172086

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02172086

Key words

Search

Navigation